HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass (IMMUNOPED)

Nantes University Hospital (NUH)

Status: Completed

Conditions: Cardiac Surgery

Treatments: Other: Blood collection

Study type: Observational

Funder types: Other

Identifiers

NCT03309839

RC17_0359

Details and patient eligibility

About

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss.

We hypothesize that HLA-DR expression in neonates is predictive of septic complications after cardiopulmonary bypass

Enrollment: 50 patients

Sex: All

Ages: Under 28 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged ≤ 28 days
• Admission after cardiac surgery under cardiopulmonary bypass

Exclusion criteria

• Lack of parental consent

Trial design

50 participants in 1 patient group

neonates with cardiac surgery under cardiopulmonary bypass

Treatment:

Other: Blood collection